Rationale for adjuvant idiotypic vaccination after high-dose therapy for multiple myeloma

Volker L. Reichardt, Craig Y. Okada, Keith E. Stockerl-Goldstein, Bjarne Bogen, Ronald Levy

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Fingerprint Dive into the research topics of 'Rationale for adjuvant idiotypic vaccination after high-dose therapy for multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences